• 구독신청
  • My스크랩
  • 지면신문
FNTIMES 대한민국 최고 금융 경제지
ad

What is Hyundai and Kia's Strategy to Counter Trump's Tariffs with a 40% U.S. Production Share?"

곽호룡 기자

horr@fntimes.com

기사입력 : 2025-04-10 09:05

◇ "No Price Hike Until May" Leaves Room for Adjustment
◇ Annual cost increase of KRW 9 trillion if tariff costs are borne, '33% of last year's operating profit'
◇ Likely to push for expansion of U.S. production share, currently at 40%

[Korea Financial Times, Gwak Horyung] Hyundai Motor Company and Kia Corporation are taking a cautious stance in response to the imposition of high tariffs in the United States, closely monitoring the situation. However, analysts predict that strategic adjustments in the U.S., which has been a key market driving solid performance until last year, will be inevitable.

Hyundai Motor Group Chairman Chung Eui-sun (L) and U.S. President Donald Trump announce their investment plans in the United States at the White House in Washington, DC, U.S., March 24, 2025. Photo via White House YouTube Live

Hyundai Motor Group Chairman Chung Eui-sun (L) and U.S. President Donald Trump announce their investment plans in the United States at the White House in Washington, DC, U.S., March 24, 2025. Photo via White House YouTube Live


On April 4, José Muñoz, President and CEO of Hyundai Motor America (HMA), and Song Ho Sung, President and CEO of Kia Corporation, stated, "We currently have no plans to raise prices in the U.S." This announcement came a day after former U.S. President Donald Trump implemented a 25% tariff on imported vehicles, signaling that the companies would not immediately respond with price hikes.
However, this does not mean that the company will fully bear the increased costs caused by the tariffs. The following day, HMA clarified through a press release that it would not raise the Manufacturer's Suggested Retail Price (MSRP) for new or leased vehicles until June 2, leaving open the possibility of price increases after that date.

Hyundai and Kia are not alone in temporarily freezing prices. Other automakers with local production facilities in the U.S., such as General Motors (GM), Toyota, and Honda, have made similar announcements. This approach appears to reflect their strategy to rely on locally produced vehicles while observing how the situation unfolds, especially since President Trump is leveraging tariffs as a negotiation tool.

In contrast, automakers with relatively lower stakes in the U.S. market have responded with immediate price hikes. Ferrari raised its vehicle prices in the U.S. by 10%, while Jaguar Land Rover announced it would suspend exports to the U.S. starting in April. Volkswagen and BMW have also informed that they will add dealer fees to export models subject to tariffs starting next month.

Despite their local production efforts, Hyundai and Kia face limitations in meeting U.S. demand solely with domestically produced vehicles.

At Hyundai's Alabama plant, models such as the Tucson, Santa Fe, and Genesis GV70 are manufactured. Last year, this plant produced 337,467 units for domestic sales. Given Hyundai's total U.S. sales of 911,805 units last year, only 37% of its vehicles were locally produced. Key sedan models like the Elantra (Avante) and Sonata are manufactured at Hyundai's Ulsan plant in South Korea for export. Some Tucson units are also produced at Kia's Mexico plant.
Kia's Georgia plant accounted for 352,100 units (44%) of its total U.S. sales of 796,488 units last year. Models like the Sportage, Sorento, and Telluride are produced there. Additionally, Kia's Mexico plant contributed significantly with sales of 274,490 units last year, producing key models like the K4 for the U.S. market.

U.S.factories = Hyundai Alabama, Kia Georgia / Data = each company

U.S.factories = Hyundai Alabama, Kia Georgia / Data = each company


Given Hyundai and Kia's high reliance on the U.S. market, their financial performance is expected to take a hit.

According to Lee Ji-soo, an analyst at Korea Investment & Securities Co., Ltd., who analyzed various scenarios involving tariffs on Korean automakers on April 3, Hyundai is estimated to face an annual cost increase of KRW 5.145 trillion if it absorbs a 25% tariff on its exported volume of 570,000 units from South Korea. Similarly, Kia's burden is projected at KRW 3.82 trillion under the same conditions. Combined, this amounts to KRW 8.9 trillion—equivalent to 33% of both companies' combined operating profit of KRW 26.9 trillion last year.

To mitigate tariff-related costs, there is speculation that Hyundai and Kia may consider producing internal combustion engine vehicles at their recently completed eco-friendly Meta Plant America (HMGMA) in Georgia. However, Lee noted that relocating production from South Korea would require union negotiations and limit the range of models that can be produced overseas.

The industry is closely watching Hyundai and Kia's first-quarter earnings conference call scheduled for later this month. An industry insider commented, "Even if they reiterate their commitment to freezing prices until May during this call, it will likely be difficult to exclude tariff impacts from their second-quarter earnings guidance."

Hyundai Motor Group Metaplant America (HMGMA) Overview /  source=Hyundai Motor

Hyundai Motor Group Metaplant America (HMGMA) Overview / source=Hyundai Motor

이미지 확대보기


Gwak Horyung (horr@fntimes.com)

데일리 금융경제뉴스 FNTIMES - 저작권법에 의거 상업적 목적의 무단 전재, 복사, 배포 금지
Copyright ⓒ 한국금융신문 & FNTIMES.com

가장 핫한 경제 소식! 한국금융신문의 ‘추천뉴스’를 받아보세요~

KFT Topic 다른 기사

1 Kia's Three Growth Engines Fuel Its Historic Charge Toward No. 1 The long-standing formula of South Korea's auto market — Hyundai Motor No. 1, Kia No. 2 — is showing cracks. Kia has narrowed the sales gap with Hyundai Motor to within striking distance, and forecasts that it will claim the top spot in domestic sales for the first time in its history this year are increasingly becoming reality.Kia's sales momentum is attributed to solid performance in its core SUV lineup, combined with the successful rollout of new lineups such as mass-market electric vehicle (EV) models and purpose-built vehicles (PBVs).According to Kia's disclosure on the 28th, the compan 2 SK Biopharmaceuticals Doubles Down: $795M Bet on Second Blockbuster Epilepsy Drug "SK Biopharmaceuticals has now entered a different league, one in which we compete directly with global big pharma companies in the United States and Europe, not just in Korea."President Lee Dong-hoon of SK Biopharmaceuticals made this declaration at a press conference held on the afternoon of the 26th at the Westin Josun Hotel in Jung-gu, Seoul, where he abruptly unveiled the company's license-in (L/I) agreement to acquire opakalim, an epilepsy drug candidate from Ireland-based Biohaven.Through the deal, SK Biopharmaceuticals aims to reduce its reliance on a single product — cenobamate — an 3 Naver Bets on AI Infrastructure While Kakao Bets on Agentic AI South Korea's two leading platform companies, Naver and Kakao, are maintaining similar levels of research and development (R&D) investment relative to revenue in the first half of this year, but they are pursuing markedly different strategies to secure AI competitiveness.Naver is focused on expanding AI infrastructure, while Kakao — taking its spinoff as an opportunity — is concentrating on strengthening agentic AI services.According to the Financial Supervisory Service's electronic disclosure system on the 24th, Naver's and Kakao's R&D spending in the first half of 2026 came to KRW
ad
ad
ad

한국금융 포럼 사이버관

더보기

FT카드뉴스

더보기
[그래픽 뉴스] ISA 대개편! 나에게 유리한 계좌는?
[그래픽 뉴스] 미국 증시 새로운 키워드 'MANGOS'
환전·로또·육아휴직까지 하반기부터 달라지는 제도 TOP11
[그래픽 뉴스] 은퇴후 30년 부모님 세대의 생존전략
[그래픽 뉴스] 퇴근 후 주차했는데 수익 발생? V2G의 정체

FT도서

더보기